Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Against pandemic research exceptionalismScience, 2020-05, Vol.368 (6490) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.sciencemag.org/coronavirus-research-commentary-and-news?intcmp=ghd_cov ;DOI: 10.1126/science.abc1731Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
It is unprecedented: trial management during the COVID-19 pandemic and beyondCurrent controlled trials in cardiovascular medicine, 2020-09, Vol.21 (1), p.784-784, Article 784 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1745-6215 ;EISSN: 1745-6215 ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-020-04711-6 ;PMID: 32917258Full text available |
|
3 |
Material Type: Article
|
Developing Covid-19 Vaccines at Pandemic SpeedNew England Journal of Medicine, 2020-05, Vol.382 (21), p.1969-1973 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2005630 ;PMID: 32227757Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine ApprovalViruses, 2020-12, Vol.13 (1), p.54 [Peer Reviewed Journal]2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the author. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v13010054 ;PMID: 33396343Full text available |
|
5 |
Material Type: Article
|
COVID-19 and readjusting clinical trialsThe Lancet, 2020-08, Vol.396 (10250), p.523-524 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31787-6 ;PMID: 32828180Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2The Lancet Infectious Diseases, 2021-02, Vol.21 (2), p.e26-e35 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2021. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30773-8 ;PMID: 33125914Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
SARS-CoV-2 Vaccines: Status ReportImmunity, 2020-04, Vol.52 (4), p.583-589 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Inc. ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2020.03.007 ;PMID: 32259480Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Trustworthiness before Trust — Covid-19 Vaccine Trials and the Black CommunityNew England Journal of Medicine, 2020-11, Vol.383 (22), p.e121-e121 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp2030033 ;PMID: 33064382Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspectiveOrphanet journal of rare diseases, 2023-04, Vol.18 (1), p.79-79, Article 79 [Peer Reviewed Journal]2023. The Author(s). ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1750-1172 ;EISSN: 1750-1172 ;DOI: 10.1186/s13023-023-02693-7 ;PMID: 37041605Full text available |
|
10 |
Material Type: Article
|
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidatesThe Lancet, 2020-11, Vol.396 (10262), p.1595-1606 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32137-1 ;PMID: 33065034Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently neededThe Lancet, 2020-05, Vol.395 (10234), p.1407-1409 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30858-8 ;PMID: 32278362Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialJAMA, 2020-10 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.17021Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Rapid repurposing of drugs for COVID-19Science, 2020-05, Vol.368 (6493) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.sciencemag.org/coronavirus-research-commentary-and-news?intcmp=ghd_cov ;DOI: 10.1126/science.abb9332Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialJAMA, 2020-10 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.17022Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.govPloS one, 2022-01, Vol.17 (1), p.e0262114-e0262114 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Hutchinson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Hutchinson et al 2022 Hutchinson et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0262114 ;PMID: 35061758Full text available |
|
16 |
Material Type: Article
|
Emerging trends from COVID-19 research registered in the Clinical Trials Registry - IndiaIndian journal of medical research (New Delhi, India : 1994), 2021-01, Vol.153 (1), p.26-63 [Peer Reviewed Journal]COPYRIGHT 2021 Indian Council of Medical Research ;COPYRIGHT 2021 Medknow Publications and Media Pvt. Ltd. ;2021. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright: © 2021 Indian Journal of Medical Research 2021 ;ISSN: 0971-5916 ;EISSN: 0975-9174 ;DOI: 10.4103/ijmr.IJMR_2556_20 ;PMID: 33818466Full text available |
|
17 |
Material Type: Article
|
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical TrialJAMA, 2020-10 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.16761Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical TrialJAMA, 2021-07, Vol.326 (1), p.35 [Peer Reviewed Journal]2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2021.8565Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
A Review of SARS-CoV-2 and the Ongoing Clinical TrialsInternational journal of molecular sciences, 2020-04, Vol.21 (7), p.2657 [Peer Reviewed Journal]2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21072657 ;PMID: 32290293Full text available |
|
20 |
Material Type: Article
|
Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis StudyJournal of medical Internet research, 2023-03, Vol.25 (1), p.e39262-e39262 [Peer Reviewed Journal]Janelle Applequist, Cristina Burroughs, Peter A Merkel, Marc Rothenberg, Bruce Trapnell, Robert Desnick, Mustafa Sahin, Jeffrey Krischer. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 14.03.2023. ;2023. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Janelle Applequist, Cristina Burroughs, Peter A Merkel, Marc Rothenberg, Bruce Trapnell, Robert Desnick, Mustafa Sahin, Jeffrey Krischer. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 14.03.2023. 2023 ;ISSN: 1438-8871 ;ISSN: 1439-4456 ;EISSN: 1438-8871 ;DOI: 10.2196/39262 ;PMID: 36917158Full text available |